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Abstract
Background: This study sought to understand the most common uses
and functions of mobile phones in monitoring and managing
diabetes, their potential role in a clinical setting, and the current
state of research in this area. Methods: We identified peer-reviewed
articles published between 2000 and 2010. Twenty-one articles were
analyzed for this systematic literature review. Results: The majority
of studies examined the use of mobile phones from the patient’s
perspective. Subjects with type 1 diabetes were enrolled exclusively
in over 50% of the studies. Seventy-one percent of the studies used a
study-specific application, which had supplemental features in ad-
dition to text messaging. The outcomes assessed varied considerably
across studies, but some positive trends were noted, such as
improved self-efficacy, hemoglobin A1c, and self-management be-
haviors. Conclusions: The studies evaluated showed promise in
using mobile phones to help people with diabetes manage their
condition effectively. However, many of these studies lacked suffi-
cient sample sizes or intervention lengths to determine whether the
results might be clinically or statistically significant. Future research
should examine other key issues, such as provider perceptions, in-
tegration into a healthcare practice, and cost, which would provide
important insight into the use of mobile phones for chronic disease
management.
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Introduction
D
iabetes is a well-documented health problem in the United
States and worldwide. The Centers for Disease Control and
Prevention reports that about 25.8 million people (8.3%) in
the United States have been diagnosed with this disease.1
Worldwide, approximately 220 million people have diabetes, and
estimates suggest this number will grow to 366 million by 2030.2 Past
research has found that patients who use self-monitoring techniques,
including monitoring food intake, physical activity, and glucose
levels, have better control of their disease.3,4
One way that has been proposed to help individuals better manage
their diabetes is through use of mobile phones, which are now widely
available, offer a variety of communication methods, and are rela-
tively inexpensive. The availability of mobile phones worldwide is
growing, and at the end of 2010 the International Telecommunica-
tions Union posits that there will be an estimated 5.3 billion mobile
cellular subscriptions.5 Text messaging, also known as short message
service (SMS), is a relatively low cost way to send asynchronous
messages via mobile phones and is increasing in popularity. An es-
timated 200,000 text messages are sent every second.5 In the United
States, among teenagers (12–17 years old) who have a mobile phone,
over 54% send daily text messages, and almost half send 50 or more
text messages per day.6 Additionally, a recent report from the Pew
Research Center7 states that 7% of mobile phone users have used their
phone to search for health or medical information. This trend is
higher among younger people, as 29% of 18–29 year olds have
performed this type of search. The use and prevalence of mobile
applications are also on the rise, as evidenced by the fact that a search
for ‘‘Diabetes’’ within the iPhone (Apple) App store yields 262 results
as of March 2011.
Because of the seemingly ubiquitous nature of mobile phones,
many researchers and health providers have used mobile phones as a
way to educate or help people to manage their health issues.8–12
Similar to previous research that has examined the use of mobile
phones for diabetes,10 this study sought to examine the types of
mobile phone-based interventions implemented among people with




This study began by searching the following electronic databases:
Science Citation Index Expanded, Social Sciences Index, Art &
Humanities Citation Index, and ProQuest for peer-reviewed articles
published between 2000 and May 2010. Search terms included var-
ious combinations of the terms ‘‘diabetes,’’ ‘‘diabetes mellitus,’’
‘‘mobile phone,’’ ‘‘cell phone,’’ ‘‘cellular phone,’’ ‘‘text messaging,’’
‘‘text message,’’ ‘‘SMS,’’ and ‘‘short message service.’’ References of
identified articles were also searched for potential articles for in-
clusion. Only articles published in peer-reviewed scientific journals
in English were eligible for review. The studies reviewed also had to
use the mobile phone as the primary device of the intervention.
STUDY SELECTION
We identified 28 articles that met the basic criteria of our search.
However, when the articles were further reviewed, seven articles were
excluded, primarily because the mobile phone was not the main
study intervention technology or the article was a description of a
planned intervention that had not yet been implemented. Thus, in
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total, 21 articles were analyzed for this systematic literature review
(Table 1). All articles were independently reviewed and coded by
the authors, and the following data were extracted: self-care/
management activities (i.e., glucose monitoring, eating/diet, physical
activity), method of intervention (i.e., application, text messaging
only, combination), intervention activity (i.e., diary/log, reminder,
informational), outcomes measured (i.e., hemoglobin A1c [HbA1c],
body mass index [BMI], self-efficacy, knowledge, satisfaction/
usefulness), and method of data transmittal. Additionally, study de-
sign and duration, type and glycemic control of diabetes, sample size,
study participant (i.e., patient, physician, nurse, informal caregiver)
recruitment process, phone ownership, location, costs, and reported
technical issues were examined (Table 2). Both coders had previous
coding experience and were well versed in the area of mobile health.
During the process of establishing reliability, the coding scheme was
refined and explicated as necessary. Once reliability was established
(Krippendorff’s alpha ‡ 0.8 for each coded item), any discrepancies
between the two reviewers were subject to multiple reviews and then
settled by consensus.
Results
STUDY DESIGNS AND SUBJECTS
The majority (95%) of studies examined the use of mobile phones
from the patient perspective, while 19% took into account the
healthcare providers (physicians [14%], nurses [5%]), and two studies
(9.5%) included informal caregivers, such as parents of the patient.
Sample sizes ranged from 6 to 100 subjects, with a mean of 38
subjects and a median number of 30. Subjects with type 1 diabetes
were used exclusively in 57% of the studies, 19% had patients with
type 2 diabetes only, 10% of the studies used patients with both types,
and 14% of the studies did not report this information. Level of
glycemic control, as measured by HbA1c, was reported in 57% of
studies.
Almost half of the studies had some type of participant random-
ization (47.6%). Two studies utilized a crossover design in their in-
tervention. The length of the interventions varied from 2 weeks to 1
year. The average length of intervention was 22.5 weeks, excluding
two studies that did not report intervention length. Fourteen of the 21
studies described participant inclusion and exclusion criteria. Having
a comorbidity was the most commonly stated exclusionary factor
(23.8%), whereas the most commonly reported inclusion criterion
involved participant age (62%). Treatment with insulin was required
by one-third of studies. Seventy-one percent of studies explicitly
stated the location of the intervention; these studies took place in the
United Kingdom (n = 5), the United States (n = 4), Scandinavia (n = 3),
and continental Europe (n = 2).
MOBILE PHONE TECHNOLOGIES
Over half of studies (57%) provided a mobile phone to the subjects,
whereas 14% had subjects use their own phone, and 29% did not
report this information. One-third of studies stated that the study paid
for the mobile phone service, and two-thirds of studies did not report
who paid for the service. Additionally, four studies discussed overall
cost data. Technical issues, such as lost messages or limitations of
coverage area, were reported in 67% of studies.
Seventy-one percent of studies used a study-specific application,
which is a program that was developed for the study and has more
functionalities or features than simple text messaging. The type of
function (i.e., diary/log, reminders, information/education) used in
the intervention varied, and many studies included multiple func-
tions. Messages that reminded the participant to do an activity were
used in 52% of the studies. Six studies (39%) used the messages as an
opportunity to educate the participants with tips and information
about diabetes. Eighty-one percent of studies reported using a diary
function to record data such as blood glucose readings, carbohydrate
or calorie consumption, or physical activity. The most common
transmission methods of blood glucose values were Bluetooth
(Bluetooth SIG, Inc.) (62.5%), a physical wire to the phone (12.5%), or
infrared signaling (12.5%) between the phone and the glucometer.
Studies that did not develop or use a study-specific application used
text messaging only. In these instances, subjects had to manually
enter their information into the mobile phone and send it.
OUTCOMES REPORTED
The studies reviewed used many different outcome measures,
making it difficult to do a rigorous analysis of the clinical findings.
Outcomes related to self-care and management activities were re-
ported by 43% of studies. These activities included glucose moni-
toring (67%), eating (44%), and exercise (44%). Sixty-two percent of
studies reported HbA1c as an outcome measure, of which 85% re-
ported improvements. However, statistically significant changes in
HbA1c were reported in only three of the studies. BMI was an out-
come in 24% of studies, and no significant changes were found. Self-
efficacy was reported as an outcome by 24% of studies, and all found
nonsignificant improvements. Knowledge about diabetes and dia-
betes management was reported as an outcome in 14.3% of studies,
with improvements reported in two studies. Information about the
costs associated with this type of intervention was reported in four
studies. Of the 48% of studies that reported satisfaction as an outcome
measure, 90% of them reported that the subjects were satisfied with
this type of intervention.
Discussion
This review highlights the work that has been done in using mobile
phones to help people with diabetes manage their disease and im-
prove health and behavior outcomes. When one considers the
ubiquity of mobile phones in modern life and their increasing use for
health applications, the amount of research conducted about using
them for diabetes management seems comparatively small. The
studies evaluated demonstrate many positive trends, but few sig-
nificant findings were reported. The small number of significant
findings could be due to the small sample sizes; the average number
of subjects in the studies reviewed here was 38, and just under half
were randomized to a condition. Also worth noting is the fact that
many of the studies did not report power calculations. Thus, overall,
the generalizability of the data as they relate to other populations is
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Type 1 Technology use: High agreement regarding
subjects used this device the same or
more than normal glucometer, used
diabetes phone as communication tool.
Satisfaction/usefulness: High agreement
regarding subjects liked the mobile
technology, having the glucometer contained
within their phone. Moderate agreement
regarding ease of use and usefulness.
Neutral regarding the usefulness of Web
site, ease of contacting their physician.
Social outcomes: High agreement that it
made it easier to get around at school.
Neutral regarding impact on relationship
with physician, frequency of communication
with physician.




















Clinical outcomes: There were no
differences between the telemonitoring
group and the control arm in HbA1c
( p = 0.17). Subjects who completed the
entire telemonitoring intervention
(numbers not indicated) had a





















Type 2 Clinical outcomes: Statistically significant
improvements in HbA1c values. Subjects in
intervention were more likely to have their
physician intensify diabetes medications.






















Type 2 Clinical outcomes: Improved levels of
HbA1c.
Self-care: Improvement in self-efficacy,













Type 1 Clinical outcomes: Nonsignificant
improvement in HbA1c. Quality of life was
improved. No difference in number of
hypoglycemic episodes between groups.
Self-care: Improved adherence to testing

















Satisfaction/usefulness: They found their
approach has value. Found implications for
future research regarding insulin pumps.

























Type 1 Technology use: Over 57,000 messages
were collected.
Clinical outcomes: Increased numbers of
patients achieved HbA1c of < 8% (not
significant).
Self-care: Phone-based feedback prompted
attention to glucose levels to allow users to
adjust insulin. Regular blood glucose
monitoring was higher among intervention
group (not significant).
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Type 2 Technology use: Two subjects in the
intervention group were completely
adherent; four subjects used the
intervention for 1–2 months; four subjects
used it for 1 week; five did not transmit
information.
Satisfaction/usefulness: Technical problems
were reported with equipment. Usability
issues: Too many menus, small buttons,
commands changed frequently. Most















Technology use: Average of 33 SMS
messages per month from 23 subjects.
Reduction of messages during the holidays.
Satisfaction/usefulness: Overall user
satisfaction was good (n = 6 responses).
Cost: The cost analysis was based on
subjects using their own phone and SIM
card and estimate e3/month for the user
















Type 1 Technology use: 1,180 messages were
submitted during the study period. Five
subjects used the system the majority of
the time (52% of all messages). Female
subjects sent more messages not regarding
diabetes. Unprompted submission of blood
glucose was most common message type.
Responses to requests for personal
experience and tips accounted for 40%
of incoming messages as well as asking
questions and ordering supplies. Subjects
did not request that an outside (of the


































Type 1 Technology use: System was used 3–4
times/day.
Satisfaction/usefulness: When the children
were away from home, both groups
thought the automatic transfer of blood
glucose levels was good. The parents had
higher levels of satisfaction than the
children. All parents felt the system
provided reassurance. Parents liked
knowing if their child has measured his or
her blood glucose. Information provided
was good for recently diagnosed children.
Individuals thought the system should be
more automated.
Self-care: Living with diabetes was easier
with the phone.
Social outcomes: Mixed interview findings
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Type 1 Technology use: Average number of blood
glucose readings transferred was 9.1/week.
Subjects who were identified as working in
a technical field sent more messages.
Clinical outcomes: Insulin dose of the
intervention group increased significantly.
Slight overall increase in HbA1c for both
groups (minor change in methodology of









11 11 weeks Randomized, test
the feasibility
and acceptability









Type 1 Satisfaction/usefulness: Generally positive
feedback regarding the system. Findings
indicate the system was good at providing
new and updated information about
diabetes and information about the
























Technology use: 18 subjects used the text
messaging system; 11 of the e-mail
subjects used the system. Females were
more likely to use the system. Cell phone
group requested more reminders,
responded faster to reminders, and
submitted significantly more blood glucose
test results. Between-group difference
decreased as time went on.
Satisfaction/usefulness: Half of all subjects
reported they would prefer the cell phone;
17% preferred the e-mail; 10% wanted
both; two subjects did not prefer either.
Clinical outcomes: No difference in glycemic














Type 1 Technology use: 3,850 log-ins were
registered over the entire program; 13,003
datasets were transmitted; 85% adherence
rate of sending at least three blood glucose
values daily. An average log-on and data
transfer took approximately 3 min.
Satisfaction/usefulness: Application was
easy to learn and use.
Clinical outcomes: Significant decrease in
















Type 1 Technology use: Nine patients sent only
< 50% of the 4 daily messages.
Clinical outcomes: Group using phone
application demonstrated improved
glycemic control.
Satisfaction/usefulness: Some service area
coverage problems were reported by 26
subjects. Patients reported overall
satisfaction with the application. Patients
did not like the additional workload or the
service area problems.
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Type 1 DID1: Technology use: Patients sent
average of 10.4 messages per day.
Satisfaction/usefulness: Baseline
perceptions of the system were
good.
Patients were interested in trying it and
thought it could be helpful. Post-study
survey concluded the system led
to good satisfaction and was useful,
easy to use, and easy to learn. CHO
counting tool was ranked the most
important function, followed by insulin
bolus calculator, food diary, physical
activity diary, and food exchange.
Communication with provider was
ranked as being effective. Technical
issues included the speed.
Clinical outcomes: No significant
differences were shown in HbA1c,
blood pressure, BMI, DTSQ-WHO,
and SF-36.
Self-care: Subjects reported better
eating behaviors and reported higher
knowledge of diabetes.
DID2: Clinical outcomes: Fasting blood
glucose and postprandial blood glucose
decreased significantly. HbA1c decreased
(not significant). Short-acting insulin use





















Type 1 Technology use: 58 responses; 132
hypoglycemic reports over 705
recorded days. Response rate
of the mobile phone group was
95%, paper diary 65%, and computer
application 89%.
Satisfaction/usefulness:




















Type 2 Technology use: 160 blood glucose
readings were transmitted per patient.
Satisfaction/usefulness: Providers reported
they liked the ability to access up-to date
information, potential to support patient
self-management, and enhancing patient
self-management. Technical problems were
also reported and addressed during the
study.
Clinical outcomes: Decrease in HbA1c
(not significant).
Self-care: Patients reported feeling more
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limited. To move the field forward this issue should be addressed in
all future studies. A limitation of this review, however, is that the
assessment of outcomes reported was done at a more general level so
as to allow for comparison across studies. HbA1c was commonly
monitored, but other condition-specific factors assessed by the
studies were not completely addressed in this review. It may be the
case that the outcomes were more promising for other parameters not
discussed here.
Short intervention periods also may have impacted the reported
outcomes. For example, the two studies13,14 that had a study period of
at least a year were able to demonstrate a significant effect of the
intervention on key outcomes. Additionally, because of the relatively
short time frames of most studies, we are unable to determine the
long-term impacts of mobile phone diabetes interventions, including
retention, adherence, sustainability, and integration into the
healthcare system. As diabetes is a condition that requires lifelong
management and monitoring, longer intervention lengths may pro-
vide better insights.
It is interesting that reports of provider interactions with the pa-
tients using the mobile phones were limited in these studies. It is not
clear how additional data regarding a patient’s diabetes were pre-
sented to either the patient’s physician or nurse and how medical
professionals then integrated this information into their practice.
Patients’ perceptions of usefulness were reported in just under half
(48%) of the studies, with most (90%) reporting that the patients
perceived the application positively. However, past research has
demonstrated that gatekeepers to the introduction of new technol-
ogies are often the healthcare providers.15 Therefore, it is important
to understand providers’ perceptions of the challenges and barriers to
integrating new technologies that might help improve patient












































that recording eating habits was motivating;
however, there was a lot of effort involved
in doing that manually. Thought the
developed tool could be useful. Photo food
blog would not be helpful but could help
with unfamiliar foods or when talking to an
HCP. Preloaded food list with nutritional
values was valuable. Touch screen
application was thought to be easy to use.
The ability to personalize the application was
















Type 1 Application was used in conjunction with
intensive therapy and compared against
those not using the application.
Technology use: Increase in hotline
contacts of those using the insulin pump
with the application compared with the
intensive therapy and the application
(significant).
Satisfaction/usefulness: 97% liked the
number of messages received.
Social outcomes: Improved perceptions of
the support they receive.
Clinical outcomes: Improvement in HbA1c
was shown in the group using the
application + intensive therapy. Health
service utilization increased stepwise across
the groups over the year but remained
within protocol.
Self-care: Significantly higher scores
on the self-efficacy measure (significant).
Improved self-adherence scores. No impact
on diabetes knowledge scores. 81%
thought that the application helped their
self-management.
AMI, acute myocardial infarction; BMI, body mass index; CHO, carbohydrate; DTSQ-WHO, Diabetes Treatment Satisfaction Questionnaire–World Health Organization;
HbA1c, hemoglobin A1c; HCP, healthcare provider; RCT, randomized controlled trial; SF-36, 36-item Short Form; SMS, short message service.
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The care taken by
individuals toward their
own health and well-
being, the actions they










Method of data transmittal
If an application was







Not used Hand-entered 38.1% 8
Intervention activity
The type of activity that
the intervention provided















In weeks, average 22.5
Type of diabetes
Was the intervention
developed for a specific
type of diabetes?
Type 1 57.1% 12
Type 2 19.0% 4
Both 9.5% 2
Not reported 14.3% 3
Outcomes BMI reported 23.8% 5
What outcomes did
the study examine?




No change 19.0% 1
Knowledge reported 14.3% 3
Improvement 66.7% 2





Satisfaction reported 47.6% 10
Satisfactory/useful 90.0% 9
Mixed 10.0% 1
Self-efficacy reported 23.8% 5
Improvement 100.0% 5
No change 0.0%
HbA1c reported 61.9% 13
Improvement 84.6% 11
No change 7.7% 1
Deterioration 7.7% 1
Sample size
Was the sample size




Recruitment process Inclusion criteria





Severity of diabetes 28.6% 6
Length of diagnoses 23.8% 5
Insulin treatment 33.3% 7
Access to Internet 14.3% 1




Mental illness 9.5% 2







Who provided the phone? Study provided phone 57.1% 12
Subjects use own phone 14.3% 3
Not reported 28.6% 6
Study location
Was the location
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outcomes. There may be some hesitation by a healthcare provider or
facility in adopting this type of technology, as questions of reim-
bursement, privacy, and liability may be issues. However, these issues
may be addressed by the Food and Drug Administration, which is
taking steps to formally approve these types of applications for use in
healthcare.
Many healthcare providers and organizations are searching for
cost-effective ways of providing high-quality healthcare to patients,
and using mobile phones may prove to be one effective strategy.
However, cost issues were only mentioned in four of the studies,25,30–32
and none mentioned reimbursement issues. Cost analysis greatly
depends on the equipment used and the timing associated with the
intervention, but it will never be truly accurate without measuring
the costs when implemented in the ‘‘real-world.’’ Another real-world
issue regards the provision of the mobile phones to the patients. Many
of these studies provided the mobile phones to the patients, so it is
unclear if they had their own phone and if the studies’ technologies
would have worked on them. Moreover, it is unknown if participants
felt burdened when having to carry a second, unfamiliar phone,
which could also lead to different patterns of usage than if they had
used their own device. These issues are important for future studies to
address if there are widespread implementation plans.
Overall, subjects’ use and engagement in the mobile phone tech-
nologies utilized in the studies remain unclear. Some studies reported
the number of text messages received and sent as an outcome mea-
sure, but it is impossible to gauge the actual level of patient en-
gagement by this metric alone. Some studies only had a fraction of
the participants respond to additional surveys that measured such
outcomes. Additionally, in the studies that assessed the quantity and
frequency of the messages, most report that a few highly active users
sent the majority of the messages. Further inquiry is therefore needed
to examine the characteristics of these highly active individuals and
to work toward determining methods of encouraging other users to
become more active. More engaged patients might demonstrate
higher self-efficacy in managing their illnesses on a daily basis
through use of mobile phones. In the studies reviewed, only a quarter
(24%) measured self-efficacy,13,16–19 with all reporting improve-
ments. These improvements may lead to behavior change and better
outcomes over time, but this is unlikely if the subjects do not con-
tinue using the technology or are not engaged in the activity.
Future research on the use of mobile phones for improving access
and quality of healthcare is seemingly endless, as many mobile ap-
plications for health are being developed, and mobile phones con-
tinue to become more prevalent. However, many of these potential
applications may be outside of the purview of an individual’s
healthcare team or insurance company; thus access to or awareness
of quality or formally approved technologies could be limited. Future
studies should examine healthcare providers’ acceptance and in-
tention to work mobile phone applications into their practices as well
as the impact that these applications might have on patient–provider
interaction. Furthermore, research could explore if there is a differ-
ence in outcomes between an individual independently deciding to
use an application versus having an application recommended by his
or her healthcare provider. It is also important to determine the
characteristics of patients who would actually use the mobile phones
and consequently benefit the most from their use in order to define
appropriate referral strategies. Again, future study designs and im-
plementation will need to address the long-term sustainability and
outcomes for these types of applications. These types of research
inquiries will help to inform the efficient and effective use of mobile
phones in managing chronic diseases.
This systematic review has examined studies that used mobile
phones to help people manage their diabetes. However, many of the
studies evaluated did not use rigorous study designs, and few sta-
tistically significant results in patient outcomes were found. Never-
theless, there is promise in that many of the outcomes had positive
trends, such as for HbA1c levels, self-efficacy, and diabetes knowl-
edge. Altogether, the studies analyzed suggest that, despite the
promise of using mobile phones in this area, much more rigorous
research needs to be completed if these technologies are to be proven
useful in the management of diabetes.
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